Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Response to the letter to the editor on "an indirect treatment comparison of the efficacy of patisiran and tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy".

Lin H, Agarwal S, Betts M, Fahrbach K, Chitnis M, Polydefkis M.

Expert Opin Pharmacother. 2019 May 24:1-2. doi: 10.1080/14656566.2019.1620987. [Epub ahead of print] No abstract available.

PMID:
31124741
2.

Pain mechanisms in hereditary palmoplantar keratodermas.

Weinberg RL, Coulombe PA, Polydefkis M, Caterina MJ.

Br J Dermatol. 2019 Mar 18. doi: 10.1111/bjd.17880. [Epub ahead of print] Review.

PMID:
30883689
3.

An indirect treatment comparison of the efficacy of patisiran and tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy.

Planté-Bordeneuve V, Lin H, Gollob J, Agarwal S, Betts M, Fahrbach K, Chitnis M, Polydefkis M.

Expert Opin Pharmacother. 2019 Mar;20(4):473-481. doi: 10.1080/14656566.2018.1554648. Epub 2018 Dec 12. Review.

PMID:
30489166
4.

Oligonucleotide Drugs for Transthyretin Amyloidosis.

Adams D, Hawkins PN, Polydefkis M.

N Engl J Med. 2018 Nov 22;379(21):2086. doi: 10.1056/NEJMc1810994. No abstract available.

PMID:
30484624
5.

Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models.

Chiorazzi A, Wozniak KM, Rais R, Wu Y, Gadiano AJ, Farah MH, Liu Y, Canta A, Alberti P, Rodriguez-Menendez V, Meregalli C, Fumagalli G, Monza L, Pozzi E, Vornov JJ, Polydefkis M, Pietra C, Slusher BS, Cavaletti G.

Eur J Pharmacol. 2018 Dec 5;840:89-103. doi: 10.1016/j.ejphar.2018.09.029. Epub 2018 Sep 27.

PMID:
30268665
6.

Nociceptin/orphanin FQ opioid peptide-receptor expression in pachyonychia congenita.

Pan B, Schröder W, Jostock R, Schwartz M, Rosson G, Polydefkis M.

J Peripher Nerv Syst. 2018 Dec;23(4):241-248. doi: 10.1111/jns.12288. Epub 2018 Oct 16.

PMID:
30255608
7.

Hereditary transthyretin amyloidosis: baseline characteristics of patients in the NEURO-TTR trial.

Waddington-Cruz M, Ackermann EJ, Polydefkis M, Heitner SB, Dyck PJ, Barroso FA, Wang AK, Berk JL, Dyck PJB, Monia BP, Hughes SG, Tai L, Jesse Kwoh T, Jung SW, Coelho T, Benson MD, Gertz MA.

Amyloid. 2018 Sep;25(3):180-188. doi: 10.1080/13506129.2018.1503593. Epub 2018 Aug 31.

PMID:
30169969
8.

Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis.

Benson MD, Waddington-Cruz M, Berk JL, Polydefkis M, Dyck PJ, Wang AK, Planté-Bordeneuve V, Barroso FA, Merlini G, Obici L, Scheinberg M, Brannagan TH 3rd, Litchy WJ, Whelan C, Drachman BM, Adams D, Heitner SB, Conceição I, Schmidt HH, Vita G, Campistol JM, Gamez J, Gorevic PD, Gane E, Shah AM, Solomon SD, Monia BP, Hughes SG, Kwoh TJ, McEvoy BW, Jung SW, Baker BF, Ackermann EJ, Gertz MA, Coelho T.

N Engl J Med. 2018 Jul 5;379(1):22-31. doi: 10.1056/NEJMoa1716793.

9.

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis.

Adams D, Gonzalez-Duarte A, O'Riordan WD, Yang CC, Ueda M, Kristen AV, Tournev I, Schmidt HH, Coelho T, Berk JL, Lin KP, Vita G, Attarian S, Planté-Bordeneuve V, Mezei MM, Campistol JM, Buades J, Brannagan TH 3rd, Kim BJ, Oh J, Parman Y, Sekijima Y, Hawkins PN, Solomon SD, Polydefkis M, Dyck PJ, Gandhi PJ, Goyal S, Chen J, Strahs AL, Nochur SV, Sweetser MT, Garg PP, Vaishnaw AK, Gollob JA, Suhr OB.

N Engl J Med. 2018 Jul 5;379(1):11-21. doi: 10.1056/NEJMoa1716153.

10.

Erratum: Author Correction: LepVax, a defined subunit vaccine that provides effective pre-exposure and post-exposure prophylaxis of M. leprae infection.

Duthie MS, Pena MT, Ebenezer GJ, Gillis TP, Sharma R, Cunningham K, Polydefkis M, Maeda Y, Makino M, Truman RW, Reed SG.

NPJ Vaccines. 2018 May 15;3:18. doi: 10.1038/s41541-018-0055-7. eCollection 2018.

11.

LepVax, a defined subunit vaccine that provides effective pre-exposure and post-exposure prophylaxis of M. leprae infection.

Duthie MS, Pena MT, Ebenezer GJ, Gillis TP, Sharma R, Cunningham K, Polydefkis M, Maeda Y, Makino M, Truman RW, Reed SG.

NPJ Vaccines. 2018 Mar 28;3:12. doi: 10.1038/s41541-018-0050-z. eCollection 2018. Erratum in: NPJ Vaccines. 2018 May 15;3:18.

12.

Reply: Non-freezing cold injury: a multi-faceted syndrome.

Vale TA, Symmonds M, Polydefkis M, Byrnes K, Rice ASC, Themistocleous AC, Bennett DLH.

Brain. 2018 Feb 1;141(2):e10. doi: 10.1093/brain/awx325. No abstract available.

PMID:
29315377
13.

Peripheral Neuropathy Induced by Microtubule-Targeted Chemotherapies: Insights into Acute Injury and Long-term Recovery.

Wozniak KM, Vornov JJ, Wu Y, Liu Y, Carozzi VA, Rodriguez-Menendez V, Ballarini E, Alberti P, Pozzi E, Semperboni S, Cook BM, Littlefield BA, Nomoto K, Condon K, Eckley S, DesJardins C, Wilson L, Jordan MA, Feinstein SC, Cavaletti G, Polydefkis M, Slusher BS.

Cancer Res. 2018 Feb 1;78(3):817-829. doi: 10.1158/0008-5472.CAN-17-1467. Epub 2017 Nov 30.

14.

Chronic non-freezing cold injury results in neuropathic pain due to a sensory neuropathy.

Vale TA, Symmonds M, Polydefkis M, Byrnes K, Rice ASC, Themistocleous AC, Bennett DLH.

Brain. 2017 Oct 1;140(10):2557-2569. doi: 10.1093/brain/awx215.

15.

Cutaneous nerve biomarkers in transthyretin familial amyloid polyneuropathy.

Ebenezer GJ, Liu Y, Judge DP, Cunningham K, Truelove S, Carter ND, Sebastian B, Byrnes K, Polydefkis M.

Ann Neurol. 2017 Jul;82(1):44-56. doi: 10.1002/ana.24972. Epub 2017 Jun 20.

PMID:
28598015
16.

An oral form of methylglyoxal-bis-guanylhydrazone reduces monocyte activation and traffic to the dorsal root ganglia in a primate model of HIV-peripheral neuropathy.

Lakritz JR, Yalamanchili S, Polydefkis MJ, Miller AD, McGrath MS, Williams KC, Burdo TH.

J Neurovirol. 2017 Aug;23(4):568-576. doi: 10.1007/s13365-017-0529-9. Epub 2017 May 1.

17.

The Potential Role of Sensory Testing, Skin Biopsy, and Functional Brain Imaging as Biomarkers in Chronic Pain Clinical Trials: IMMPACT Considerations.

Smith SM, Dworkin RH, Turk DC, Baron R, Polydefkis M, Tracey I, Borsook D, Edwards RR, Harris RE, Wager TD, Arendt-Nielsen L, Burke LB, Carr DB, Chappell A, Farrar JT, Freeman R, Gilron I, Goli V, Haeussler J, Jensen T, Katz NP, Kent J, Kopecky EA, Lee DA, Maixner W, Markman JD, McArthur JC, McDermott MP, Parvathenani L, Raja SN, Rappaport BA, Rice ASC, Rowbotham MC, Tobias JK, Wasan AD, Witter J.

J Pain. 2017 Jul;18(7):757-777. doi: 10.1016/j.jpain.2017.02.429. Epub 2017 Feb 27. Review.

18.

Sensory and autonomic function and structure in footpads of a diabetic mouse model.

Liu Y, Sebastian B, Liu B, Zhang Y, Fissel JA, Pan B, Polydefkis M, Farah MH.

Sci Rep. 2017 Jan 27;7:41401. doi: 10.1038/srep41401.

19.

Assessing mNIS+7Ionis and international neurologists' proficiency in a familial amyloidotic polyneuropathy trial.

Dyck PJ, Kincaid JC, Dyck PJB, Chaudhry V, Goyal NA, Alves C, Salhi H, Wiesman JF, Labeyrie C, Robinson-Papp J, Cardoso M, Laura M, Ruzhansky K, Cortese A, Brannagan TH 3rd, Khoury J, Khella S, Waddington-Cruz M, Ferreira J, Wang AK, Pinto MV, Ayache SS, Benson MD, Berk JL, Coelho T, Polydefkis M, Gorevic P, Adams DH, Plante-Bordeneuve V, Whelan C, Merlini G, Heitner S, Drachman BM, Conceição I, Klein CJ, Gertz MA, Ackermann EJ, Hughes SG, Mauermann ML, Bergemann R, Lodermeier KA, Davies JL, Carter RE, Litchy WJ.

Muscle Nerve. 2017 Nov;56(5):901-911. doi: 10.1002/mus.25563. Epub 2017 Apr 7.

20.

Peripheral neuropathic changes in pachyonychia congenita.

Pan B, Byrnes K, Schwartz M, Hansen CD, Campbell CM, Krupiczojc M, Caterina MJ, Polydefkis M.

Pain. 2016 Dec;157(12):2843-2853.

PMID:
27776012
21.

Epidermal innervation as a tool to study human axonal regeneration and disease progression.

Khoshnoodi MA, Ebenezer GJ, Polydefkis M.

Exp Neurol. 2017 Jan;287(Pt 3):358-364. doi: 10.1016/j.expneurol.2016.06.016. Epub 2016 Jun 15. Review. No abstract available.

PMID:
27317299
22.

Longitudinal Assessment of Small Fiber Neuropathy: Evidence of a Non-Length-Dependent Distal Axonopathy.

Khoshnoodi MA, Truelove S, Burakgazi A, Hoke A, Mammen AL, Polydefkis M.

JAMA Neurol. 2016 Jun 1;73(6):684-90. doi: 10.1001/jamaneurol.2016.0057.

PMID:
27065313
23.

Sweat Gland Denervation in Cerebellar Ataxia with Neuropathy and Vestibular Areflexia Syndrome (CANVAS).

Umeh CC, Polydefkis M, Chaudhry V, Zee DS.

Mov Disord Clin Pract. 2016 Apr 5;4(1):46-48. doi: 10.1002/mdc3.12355. eCollection 2017 Jan-Feb.

24.

Absence of a Primary Role for SCN10A Mutations in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.

Te Riele AS, James CA, Murray B, Tichnell C, Amat-Alarcon N, Burks K, Tandri H, Calkins H, Polydefkis M, Judge DP.

J Cardiovasc Transl Res. 2016 Feb;9(1):87-9. doi: 10.1007/s12265-015-9670-0. Epub 2016 Jan 5.

PMID:
26733327
25.

Structural and functional characterization of nerve fibres in polyneuropathy and healthy subjects.

Karlsson P, Haroutounian S, Polydefkis M, Nyengaard JR, Jensen TS.

Scand J Pain. 2016 Jan;10:28-35. doi: 10.1016/j.sjpain.2015.08.007. Epub 2015 Oct 2.

PMID:
28361768
26.

Loss of intraepidermal nerve fiber density during SIV peripheral neuropathy is mediated by monocyte activation and elevated monocyte chemotactic proteins.

Lakritz JR, Robinson JA, Polydefkis MJ, Miller AD, Burdo TH.

J Neuroinflammation. 2015 Dec 18;12:237. doi: 10.1186/s12974-015-0456-8.

27.

Symptomatic and Electrodiagnostic Features of Peripheral Neuropathy in Scleroderma.

Paik JJ, Mammen AL, Wigley FM, Shah AA, Hummers LK, Polydefkis M.

Arthritis Care Res (Hoboken). 2016 Aug;68(8):1150-7. doi: 10.1002/acr.22818.

28.

Safety and efficacy of ranirestat in patients with mild-to-moderate diabetic sensorimotor polyneuropathy.

Polydefkis M, Arezzo J, Nash M, Bril V, Shaibani A, Gordon RJ, Bradshaw KL, Junor RW; Ranirestat Study Group.

J Peripher Nerv Syst. 2015 Dec;20(4):363-71. doi: 10.1111/jns.12138.

PMID:
26313450
29.

Monocyte Traffic, Dorsal Root Ganglion Histopathology, and Loss of Intraepidermal Nerve Fiber Density in SIV Peripheral Neuropathy.

Lakritz JR, Bodair A, Shah N, O'Donnell R, Polydefkis MJ, Miller AD, Burdo TH.

Am J Pathol. 2015 Jul;185(7):1912-23. doi: 10.1016/j.ajpath.2015.03.007. Epub 2015 May 5.

30.

Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendations.

Gewandter JS, Dworkin RH, Turk DC, Farrar JT, Fillingim RB, Gilron I, Markman JD, Oaklander AL, Polydefkis MJ, Raja SN, Robinson JP, Woolf CJ, Ziegler D, Ashburn MA, Burke LB, Cowan P, George SZ, Goli V, Graff OX, Iyengar S, Jay GW, Katz J, Kehlet H, Kitt RA, Kopecky EA, Malamut R, McDermott MP, Palmer P, Rappaport BA, Rauschkolb C, Steigerwald I, Tobias J, Walco GA.

Pain. 2015 Jul;156(7):1184-97. doi: 10.1097/j.pain.0000000000000191. Review.

31.

Characterization of Vestibulopathy in Individuals with Type 2 Diabetes Mellitus.

Ward BK, Wenzel A, Kalyani RR, Agrawal Y, Feng AL, Polydefkis M, Ying HS, Schubert MC, Zuniga MG, Della Santina CC, Carey JP.

Otolaryngol Head Neck Surg. 2015 Jul;153(1):112-8. doi: 10.1177/0194599815576717. Epub 2015 Mar 31.

PMID:
25829391
32.

Factors influencing sweat gland innervation in diabetes.

Liu Y, Billiet J, Ebenezer GJ, Pan B, Hauer P, Wei J, Polydefkis M.

Neurology. 2015 Apr 21;84(16):1652-9. doi: 10.1212/WNL.0000000000001488. Epub 2015 Mar 25.

PMID:
25809300
33.

Structural and functional assessment of skin nerve fibres in small-fibre pathology.

Karlsson P, Nyengaard JR, Polydefkis M, Jensen TS.

Eur J Pain. 2015 Sep;19(8):1059-70. doi: 10.1002/ejp.645. Epub 2014 Dec 24. Review.

PMID:
25546653
34.

Ixabepilone-induced mitochondria and sensory axon loss in breast cancer patients.

Ebenezer GJ, Carlson K, Donovan D, Cobham M, Chuang E, Moore A, Cigler T, Ward M, Lane ME, Ramnarain A, Vahdat LT, Polydefkis M.

Ann Clin Transl Neurol. 2014 Sep;1(9):639-49. doi: 10.1002/acn3.90. Epub 2014 Sep 2.

35.

Epidermal innervation in diabetes.

Ebenezer G, Polydefkis M.

Handb Clin Neurol. 2014;126:261-74. doi: 10.1016/B978-0-444-53480-4.00020-5. Review.

PMID:
25410228
36.

Cutaneous collateral axonal sprouting re-innervates the skin component and restores sensation of denervated Swine osteomyocutaneous alloflaps.

Ibrahim Z, Ebenezer G, Christensen JM, Sarhane KA, Hauer P, Cooney DS, Sacks JM, Schneeberger S, Lee WP, Polydefkis M, Brandacher G.

PLoS One. 2013 Oct 18;8(10):e77646. doi: 10.1371/journal.pone.0077646. eCollection 2013.

37.

Acroosteolysis in diabetes mellitus.

Baer AN, Zahr ZA, Khan S, Polydefkis M.

J Rheumatol. 2012 Dec;39(12):2364-5. doi: 10.3899/jrheum.120662. No abstract available.

PMID:
23204315
38.

Herpes zoster among persons living with HIV in the current antiretroviral therapy era.

Blank LJ, Polydefkis MJ, Moore RD, Gebo KA.

J Acquir Immune Defic Syndr. 2012 Oct 1;61(2):203-7.

39.

SIV-induced impairment of neurovascular repair: a potential role for VEGF.

Ebenezer GJ, McArthur JC, Polydefkis M, Dorsey JL, O'Donnell R, Hauer P, Adams RJ, Mankowski JL.

J Neurovirol. 2012 Jun;18(3):222-30. doi: 10.1007/s13365-012-0102-5. Epub 2012 May 2.

40.

The lateral thoracic nerve and the cutaneous maximus muscle--a novel in vivo model system for nerve degeneration and regeneration studies.

Pan B, Grünewald B, Nguyen T, Farah M, Polydefkis M, McDonald J, Schramm LP, Toyka KV, Höke A, Griffin JW.

Exp Neurol. 2012 Jul;236(1):6-18. doi: 10.1016/j.expneurol.2012.02.006. Epub 2012 Feb 14.

41.

Peripheral nerve toxic effects of nitrofurantoin.

Tan IL, Polydefkis MJ, Ebenezer GJ, Hauer P, McArthur JC.

Arch Neurol. 2012 Feb;69(2):265-8. doi: 10.1001/archneurol.2011.1120.

PMID:
22332195
42.

Skin biopsy-proven flecainide-induced neuropathy.

Burakgazi AZ, Polydefkis M, Höke A.

Muscle Nerve. 2012 Jan;45(1):144-6. doi: 10.1002/mus.22239.

PMID:
22190323
43.

Longitudinal assessment of oxaliplatin-induced neuropathy.

Burakgazi AZ, Messersmith W, Vaidya D, Hauer P, Hoke A, Polydefkis M.

Neurology. 2011 Sep 6;77(10):980-6. doi: 10.1212/WNL.0b013e31822cfc59. Epub 2011 Aug 24.

44.

Impaired neurovascular repair in subjects with diabetes following experimental intracutaneous axotomy.

Ebenezer GJ, O'Donnell R, Hauer P, Cimino NP, McArthur JC, Polydefkis M.

Brain. 2011 Jun;134(Pt 6):1853-63. doi: 10.1093/brain/awr086.

45.

Glutamate carboxypeptidase activity in human skin biopsies as a pharmacodynamic marker for clinical studies.

Rojas C, Stathis M, Polydefkis M, Rudek MA, Zhao M, Ebenezer GJ, Slusher BS.

J Transl Med. 2011 Mar 9;9:27. doi: 10.1186/1479-5876-9-27.

46.

European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society.

Lauria G, Hsieh ST, Johansson O, Kennedy WR, Leger JM, Mellgren SI, Nolano M, Merkies IS, Polydefkis M, Smith AG, Sommer C, Valls-Solé J; European Federation of Neurological Societies; Peripheral Nerve Society.

Eur J Neurol. 2010 Jul;17(7):903-12, e44-9. doi: 10.1111/j.1468-1331.2010.03023.x.

47.

Practice parameter: the evaluation of distal symmetric polyneuropathy: the role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation.

England JD, Gronseth GS, Franklin G, Carter GT, Kinsella LJ, Cohen JA, Asbury AK, Szigeti K, Lupski JR, Latov N, Lewis RA, Low PA, Fisher MA, Herrmann D, Howard JF, Lauria G, Miller RG, Polydefkis M, Sumner AJ; American Academy of Neurology; American Association of Neuromuscular and Electrodiagnostic Medicine; American Academy of Physical Medicine and Rehabilitation.

PM R. 2009 Jan;1(1):14-22. doi: 10.1016/j.pmrj.2008.11.011. Review.

PMID:
19627868
48.

Practice parameter: the evaluation of distal symmetric polyneuropathy: the role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation.

England JD, Gronseth GS, Franklin G, Carter GT, Kinsella LJ, Cohen JA, Asbury AK, Szigeti K, Lupski JR, Latov N, Lewis RA, Low PA, Fisher MA, Herrmann DN, Howard JF, Lauria G, Miller RG, Polydefkis M, Sumner AJ; American Academy of Neurology; American Association of Neuromuscular and Electrodiagnostic Medicine; American Academy of Physical Medicine and Rehabilitation.

PM R. 2009 Jan;1(1):5-13. doi: 10.1016/j.pmrj.2008.11.010. Review.

PMID:
19627867
49.

Characteristics of bortezomib- and thalidomide-induced peripheral neuropathy.

Chaudhry V, Cornblath DR, Polydefkis M, Ferguson A, Borrello I.

J Peripher Nerv Syst. 2008 Dec;13(4):275-82. doi: 10.1111/j.1529-8027.2008.00193.x.

50.

Evaluation of distal symmetric polyneuropathy: the role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review).

England JD, Gronseth GS, Franklin G, Carter GT, Kinsella LJ, Cohen JA, Asbury AK, Szigeti K, Lupski JR, Latov N, Lewis RA, Low PA, Fisher MA, Herrmann D, Howard JF, Lauria G, Miller RG, Polydefkis M, Sumner AJ; American Academy of Neurology; American Association of Neuromuscular and Electrodiagnostic Medicine; American Academy of Physical Medicine and Rehabilitation.

Muscle Nerve. 2009 Jan;39(1):106-15. doi: 10.1002/mus.21227. Review.

PMID:
19086069

Supplemental Content

Loading ...
Support Center